Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-10

FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Trulance Immediate Release (plecanatide) submitted by Salix Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trulance (plecanatide)

Snippet

SUPPL AP for TRULANCE IMMEDIATE RELEASE (PLECANATIDE)